The Life Raft Group2018-12-11T10:30:16+00:00
Loading...

OUR MISSION:

Enhancing survival and quality of life for people living with GIST through patient-powered research, education and empowerment, and global advocacy efforts.

These are our Core Values:

Real World Evidence In Action

PROJECT InterGR

Traditional models for cancer research have resulted in many breakthrough treatments for patients, but it is not enough. Project InterGR, the LRG’s approach to research through real world evidence, relies on timely, accurate data from the patient’s perspective, with patient survival as the primary objective.

GIST Collaborative Tissue Bank
GIST Trials Database
The Life Raft Group Patient Registry
SideEQ
Project Surveillance

RECENT LRG DATA

0
Patients in LRG Registry
0%
of Patient Registry members know their mutation
0
Total # of Tissue
0%
of LRG members know their Risk of Recurrence

Update your Patient Registry Information.

Update

Join The Life Raft Group.

Join Our Community

Available GIST clinical trials.

Learn About Trials

Search our database of GIST Specialists.

View Specialists
Dr. Monica Anderson

Dr. Monica Anderson

Diagnosed in 2012 with Adult GIST.

Marc Wasserman

Marc Wasserman

Diagnosed in 2006 with Adult GIST.

Bella Rocco

Bella Rocco

Diagnosed in 2009 with Pediatric
(SDH-Deficient) GIST.

HELP US SAVE LIVES

The Life Raft Group is a community and it is up to all of us to make a difference. There are many ways to help, we always need patient tissue and data in our registry. Volunteering your time or making a monetary donation also helps us drive research forward and save lives.

SHARE YOUR DATA
DONATE TO THE LRG
VOLUNTEER YOUR TIME
CONTRIBUTE YOUR TISSUE

Immunotherapy: A New Hope for GIST Treatment

By |April 1st, 2007|

A French phase I clinical trial, combining Gleevec + interleukin 2 (IL-2) should open in April 2007 at the Institute Gustave Roussy in Villejuif, France. The aim of this study, organized by a team of Professor Laurence Zitvogel’s, is to evaluate the efficacy as well as the toxicity of this medicinal combination in the treatment of various cancers, including GIST, but also to identify the presence and the action of Interferon Killer Dendritic Cells (IKDCs) in humans.

Gleevec: Revolutionizing GIST Cancer Treatment

By |March 1st, 2007|

In this month’s March 2007 newsletter, Estelle LeCointe, the director of Association Française des Patients du GIST: Ensemble contre le GIST, has shared the story of the work of Professor Laurence Zitvogel. Professor Zitvogel and her colleagues are engaged in a project combining Gleevec and immunotherapy. It has been very interesting to watch this work evolve over the last few years. This research has culminated in the discovery of a new type of immune cell (in mice) and is poised to enter clinical trials in 2007.

GDOL Los Angeles 2019

February 16, 2019 @ 8:00 AM - 5:00 PM

Keep up with the latest news, events, and opportunities to help.

To contact The Life Raft Group, please call 973-837-9092

Recent Posts

Upcoming Events

  1. GDOL Los Angeles 2019

    February 16, 2019 @ 8:00 AM - 5:00 PM